Jump to main content
Jump to site search

Issue 1, 2016
Previous Article Next Article

Syntheses and biological evaluations of highly functionalized hydroxamate containing and N-methylthio monobactams as anti-tuberculosis and β-lactamase inhibitory agents

Author affiliations

Abstract

Both the resurgence of tuberculosis (TB) and antibiotic resistance continue to threaten modern healthcare and new means of combating pathogenic bacterial infections are needed. The syntheses of monobactams possessing hydroxamate and N-methylthio functionality are described, as well as their anti-TB, in vitro β-lactamase inhibitory, and general antimicrobial evaluations. A number of compounds exhibited significant anti-TB and β-lactamase inhibitory activity, with MIC values in the range of 25 to <0.19 μM against Mycobacteria tuberculosis (M. tb), and Ki values in the range of 25–0.03 μM against purified NDM-1 and VIM-1 lystate metallo β-lactamases. This work suggests that these scaffolds may serve as promising leads in developing new antibiotics and/or β-lactamase inhibitors.

Graphical abstract: Syntheses and biological evaluations of highly functionalized hydroxamate containing and N-methylthio monobactams as anti-tuberculosis and β-lactamase inhibitory agents

Back to tab navigation

Associated articles

Supplementary files

Article information


Submitted
12 Aug 2015
Accepted
30 Sep 2015
First published
05 Oct 2015

Med. Chem. Commun., 2016,7, 141-147
Article type
Concise Article

Syntheses and biological evaluations of highly functionalized hydroxamate containing and N-methylthio monobactams as anti-tuberculosis and β-lactamase inhibitory agents

M. W. Majewski, K. D. Watson, S. Cho, P. A. Miller, S. G. Franzblau and M. J. Miller, Med. Chem. Commun., 2016, 7, 141
DOI: 10.1039/C5MD00340G

Search articles by author

Spotlight

Advertisements